Kelvin Rwegoshola

Serum Magnesium as a Predictor of Diabetic Retinopathy Severity among Type 2 Diabetic Patients at Kilimanjaro Christian Medical Centre: A One-Year Study 2024-2025

Boniface Kiondo, Kelvin Rwegoshola, Furahini Mndeme & Mchikirwa Msina · Ophthalmology Research: An International Journal · 2026

Background: Diabetic retinopathy remains a leading cause of visual impairment among patients with Type 2 diabetes mellitus. While common risk factors such as hyperglycemia and duration of diabetes are well established, the role of micronutrients like serum magnesium in the progre...

Open access Research Article 10.9734/or/2026/v21i1499

Effect of Unilateral Intravitreal Bevacizumab on Contralateral Eye and Associated Factors in Patients with Diabetic Macular Edema at Kilimanjaro Christian Medical Centre

Samson Kitomary, Kelvin Rwegoshola, Sarah Kweka & Furahini Mndeme · Ophthalmology Research: An International Journal · 2026

Background: Diabetic macular edema being a foremost cause of visual loss in the diabetic population, is typically managed with intra-vitreal anti-VEGF therapy. The unilateral intra-vitreal bevacizumab (IVB) injections are standard, but the possible bilateral effect on the un-inje...

Open access Research Article 10.9734/or/2026/v21i1497

Visual Outcomes between Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Plus Focal Laser among Patients with Diabetic Macular Edema at Kilimanjaro Christian Medical Centre 2021-2024

Eliaichi Minja, William Makupa, Kelvin Rwegoshola & Andrew Makupa · Ophthalmology Research: An International Journal · 2025

Aim: To determine visual outcome in diabetic macular edema patients treated with bevacizumab alone versus bevacizumab plus focal laser. Study Design: A retrospective cohort study Place and Duration of Study: A 1 year follow-up, conducted at Kilimanjaro Christian Medical Centre fr...

Open access Research Article 10.9734/or/2025/v20i6482